Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease

YILMAZ Y., Yonal O., Kurt R., Bayrak M., Aktas B., Ozdogan O.

HEPATITIS MONTHLY, cilt.11, sa.2, ss.103-107, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 2
  • Basım Tarihi: 2011
  • Dergi Adı: HEPATITIS MONTHLY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.103-107
  • Anahtar Kelimeler: Chronic hepatitis C, Chronic hepatitis B, Fatty liver, Fibrosis, Aspartate aminotransferases, CHRONIC HEPATITIS-C, BLOOD-TESTS, PREDICT, CIRRHOSIS, BIOPSY, FIBROSCAN(R), COINFECTION, VALIDATION, INFECTION, DIAGNOSIS
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Background: The aspartate aminotransferases (AST) to platelet ratio index (APRI) may serve as a noninvasive marker to assess liver fibrosis.